Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 712 across all filing types
Latest filing 2023-05-13 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Stock split
Regulatory Filings
2023-05-13 English
Record Date
Regulatory Filings
2023-05-13 English
Related Party Transactions
Regulatory Filings
2023-05-13 English
Financial Result Updates
Regulatory Filings
2023-05-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 80% confidence The document is a formal invitation to an earnings conference call scheduled for May 15, 2023, to discuss the operational and financial performance for Q4 and FY23. It references Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which mandates disclosure of such events. The document contains no actual financial data or analysis but only the announcement and details for participation in the call. The length is short (2850 characters), and it is clearly an intimation of a conference call, not the transcript or report itself. Therefore, the appropriate classification is 'Call Transcript' (CT) category, as it relates to the earnings call event, but since this is only an invitation and not the transcript, the best fit is still CT as per definitions, which include full text transcripts of company conference calls. However, since this is only an invitation and not the transcript, the classification should be 'Regulatory Filings' (RNS) as a fallback for announcements that do not fit other categories. But given the document is specifically an invitation to an earnings call, the best matching category is 'Call Transcript' (CT) with moderate confidence, acknowledging it is not the transcript but related to the call event. Confidence is 0.8.
2023-05-08 English
Board Meeting — Financial Results/Dividend
Board/Management Information Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the date of a forthcoming Board Meeting scheduled for May 13, 2023. The agenda includes consideration of audited financial results for the quarter/year ended March 31, 2023, dividend recommendation, and a proposal for share subdivision/split. It also mentions the closure of the trading window for insiders in compliance with SEBI regulations. The document is an announcement of the Board Meeting date and related procedural information, not the actual financial results or report. The document length is short (2624 characters) and it serves as an intimation rather than a full report. Therefore, it fits best under Board/Management Information (MANG) category, which covers announcements of board meetings and related management information.
2023-05-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.